99mTc-ADAPT6-based HER2 Imaging in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

June 5, 2020

Study Completion Date

September 5, 2020

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

SPECT

One single injection of 99mTc- ADAPT6, followed by gamma camera imaging directly post-injection and after 2, 4 and 6 hours.

Trial Locations (1)

Unknown

TomskNRMC, Tomsk

All Listed Sponsors
collaborator

KTH Royal Institute of Technology

OTHER

collaborator

Uppsala University

OTHER

lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT03991260 - 99mTc-ADAPT6-based HER2 Imaging in Breast Cancer | Biotech Hunter | Biotech Hunter